News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
ActivBiotics Cuts IPO Price To $8-$10 Per Share
November 9, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, Nov 9 (Reuters) - ActivBiotics Inc. on Thursday cut the expected price of its planned initial public offering to between $8 and $10 per share from a previous range of $12 to $14.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Mergers & acquisitions
Lilly’s early-stage M&A quest finds $1.5B deal for Calytrix’s blood cancer work
November 16, 2026
·
1 min read
·
Annalee Armstrong
Business
Their loss, our gain? Canada makes its case to Europe amid U.S. instability
November 16, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Funding
Seawolf surfaces with $100M, $1.2B Sanofi pact for redosable DNA medicines
November 16, 2026
·
1 min read
·
Gabrielle Masson
Manufacturing
PharmaLogic buys Lantheus plant to build transatlantic radiopharmaceutical CDMO
November 13, 2026
·
2 min read
·
Nick Paul Taylor